Andreas Jekle
Impact in
- Virology top 2%
- HIV Research and Treatment
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
Papers in
- Virology 14
- HIV Research and Treatment 14
-
- HIV/AIDS drug development and treatment 8
- SARS-CoV-2 and COVID-19 Research 4
- Co-authors
- Erich Gulbins (7 shared papers)Heike Grassmé (2 shared papers)Florian J.W. Lang (5 shared papers)Konrad Sandhoff (1 shared paper)Richard Kolesnick (1 shared paper)Andrea Riehle (1 shared paper)Heinz Schwarz (1 shared paper)Jürgen Berger (1 shared paper)
- Journals
- Bioorganic & Medicinal Chemistry Letters (9 papers)Antiviral Research (6 papers)Journal of Medicinal Chemistry (6 papers)Antimicrobial Agents and Chemotherapy (4 papers)Journal of Hepatology (4 papers)
- Partner nations
- United StatesGermanyBelgium
In The Last Decade
Andreas Jekle
50 papers receiving 2.1k citations
Andreas Jekle's Hit Papers
Peers
Comparison fields: 5 of 100
- Virology 261
- Infectious Diseases 386
- Immunology 370
- Molecular Biology 1.2k
- Physiology 77
Countries citing papers authored by Andreas Jekle
This map shows the geographic impact of Andreas Jekle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Jekle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Jekle more than expected).
Fields of papers citing papers by Andreas Jekle
This network shows the impact of papers produced by Andreas Jekle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Jekle. The network helps show where Andreas Jekle may publish in the future.
Co-authors
The 25 scholars most cited alongside Andreas Jekle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 550 | |
| 2 | 2005 | 202 | |
| 3 | 1999 | 161 | |
| 4 | 2000 | 124 | |
| 5 | The Substitutions L50F, E166A, and L167F in SARS-CoV-2 3CLpro Are Selected by a Protease Inhibitor In Vitro and Confer Resistance To Nirmatrelvir Hit paper breakdown → | 2023 | 121 |
| 6 | 2003 | 109 | |
| 7 | 1999 | 83 | |
| 8 | 2016 | 72 | |
| 9 | 2002 | 69 | |
| 10 | 2011 | 58 | |
| 11 | 2020 | 43 | |
| 12 | 2017 | 42 | |
| 13 | 2010 | 41 | |
| 14 | 2019 | 40 | |
| 15 | 2002 | 35 | |
| 16 | 2006 | 35 | |
| 17 | 2021 | 33 | |
| 18 | 2020 | 28 | |
| 19 | 2020 | 25 | |
| 20 | 2008 | 22 |
About Andreas Jekle
Andreas Jekle is a scholar working on Virology, Infectious Diseases, Hepatology, Immunology and Epidemiology, having authored 51 papers that have together received 2.2k indexed citations. Recurring topics across this work include HIV Research and Treatment (14 papers), Immune Cell Function and Interaction (10 papers), Hepatitis C virus research (9 papers), HIV/AIDS drug development and treatment (8 papers), Hepatitis B Virus Studies (7 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and Chemical Synthesis and Analysis (4 papers). The work is most often cited by research in Virology (261 citations), Infectious Diseases (386 citations), Immunology (370 citations), Molecular Biology (1.2k citations) and Physiology (77 citations). Andreas Jekle has collaborated with scholars based in United States, Germany and Belgium. Frequent co-authors include Erich Gulbins, Heike Grassmé, Florian J.W. Lang, Konrad Sandhoff, Richard Kolesnick, Andrea Riehle, Heinz Schwarz, Jürgen Berger, Ildikò Szabó and Jürgen Bock. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Antiviral Research, Journal of Medicinal Chemistry, Antimicrobial Agents and Chemotherapy and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.